October 2026 Monthly Meeting

On Wednesday, October 7th, the Long Island Society of Health-System Pharmacists hosted its annual Pharmacy Month celebration at Leonard’s Palazzo in Great Neck. The event provided an opportunity to recognize and thank our members for their outstanding contributions to the pharmacy profession, including pharmacists, pharmacy technicians, residents, and students.

Attendees received a special Pharmacy Month gift, a convenient portable power bank, as a token of our appreciation. We extend our sincere thanks to our vendors for their continued support of our organization and to our guest speaker, Dr. Ginzburg, for delivering an informative and engaging presentation on lipid management.

Thank you to everyone who joined us in celebrating the dedicated professionals who make a difference in our profession every day!

CE credit can be obtained here: https://www.nyschp.org/long-island-programs

Educational Program Topic:

Navigating the Latest Changes in Lipid Therapy Management

Speaker:

Regina Ginzburg, Pharm.D., CDE/CDCES, BC-ADM
Director of Clinical Pharmacy Services, Institute Family Health
Ambulatory Care Clinical Pharmacy Faculty,
Mt. Sinai Downtown Family Medicine Residency Program & Clinical Professor, St. John’s University College of Pharmacy & Health Sciences

Pharmacist Objectives:

  1. To identify the key changes in screening for hyperlipidemia, as per the 2026 ACC/AHA Dyslipidemia Guideline
  2. To apply updated risk stratification and treatment thresholds for various person types and know when to start lipid treatment
  3. To compare the updated LDL-C and non–HDL-C treatment goals across clinical scenarios
  4. To distinguish the efficacy, safety profiles, and place in therapy of newer non-statin agents
  5. To develop pharmacist-driven strategies to optimize lipid management in clinical practice

Technician Objectives:

  1. Identify the major classes of lipid-lowering medications
  2. Assist patients with medication affordability
  3. Recognize common patient-reported barriers to statin adherence
  4. Conduct prospective refill management and identify gaps in medication fills